Evaluation of the therapeutic benefit of delayed administration of erythropoietin following early hypoxic-ischemic injury in rodents

Developmental Neuroscience

Volumn 34, Issue 6, 2013, Pages 515-524

  Alexander, M L ^a   Hill, C A ^b   Rosenkrantz, T S ^c   Fitch, R H ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Auditory processing; Hypoxic ischemic encephalopathy; Language impairment; Neuroprotection

Indexed keywords

ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY RESPONSE; COGNITIVE DEVELOPMENT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HYPOTHERMIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LANGUAGE DEVELOPMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; THERAPY DELAY;

ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; HYPOXIA-ISCHEMIA, BRAIN; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 84876295539     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000345645     Document Type: Article

References (60)

1. Volpe JJ: Neurology of the Newborn. Philadelphia, Saunders, 2008, vol 5, pp 347-400.
2. Volpe JJ: Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001; 50: 553-562.
3. Aarnoudse-Moens CS, Weisglas-Kuperus N, van Goudoever JB, Oosterlaan J: Meta-analysis of neurobehavioral outcomes in very preterm and/or very low birth weight children. Pediatrics 2009; 124: 717-728.
4. Anderson CA, Arciniegas DB: Cognitive sequelae of hypoxic-ischemic brain injury: a review. NeuroRehabilitation 2010; 26: 47-63.
5. Badawi N, Keogh JM, Dixon G, Kurinczuk JJ: Developmental outcomes of newborn encephalopathy in the term infant. Indian J Pediatr 2001; 68: 527-530.
6. de Vries LS, Jongmans MJ: Long-term outcome after neonatal hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 2010; 95: 220-224.
7. Ortiz-Mantilla S, Choudhury N, Leevers H, Benasich AA: Understanding language and cognitive deficits in very low birth weight children. Dev Psychobiol 2008; 50: 107-126.
8. Jansson-Verkasola E, Valkama M, Vainionpaa L, Paakko E, Iikko E, Lehtihalmes M: Language development in very low birth weight preterm children: a follow up study. Folia Phoniatr Logop 2004; 56: 108-119.
9. Steinman KJ, Gorno-Tempini ML, Glidden DV, Kramer JH, Miller SP, Barkovich AJ, Ferriero DM: Neonatal watershed brain injury on MRI correlates with verbal IQ at four years. Pediatrics 2009; 123: 1025-1030.
10. Downie AL, Jakobson LS, Frisk V, Ushycky I: Auditory temporal processing deficits in children with periventricular brain injury. Brain Lang 2002; 80: 208-225.
11. Benasich AA, Tallal P: Infant discrimination of rapid auditory cues predicts later language impairment. Behav Brain Res 2002; 136: 31-49.
12. Choudhury N, Leppanen PHT, Leevers HJ, Benasich AA: Infant information processing and family history of specific language impairment: converging evidence for RAP deficits from two paradigms. Dev Sci 2007; 10: 213-236.
13. Tallal P: Rapid auditory processing in normal and disordered language development. J Speech Hear Res 1976; 19: 561-571.
14. Heim S, Friedman JT, Keil A, Benasich AA: Reduced sensory oscillatory activity during rapid auditory processing as a correlate of language-learning impairment. J Neurolinguistics 2011; 24: 538-555.
15. Choudhury N, Benasich AA: Maturation of auditory evoked potentials from 6 to 48 months: prediction to 3 and 4 year language and cognitive abilities. Clin Neurophysiol 2011; 122: 320-338.
16. Vannucci RC, Vannucci SJ: A model of perinatal hypoxic-ischemic brain damage. Ann NY Acad Sci 1997; 835: 234-249.
17. Vannucci RC: Hypoxic-ischemic encephalopathy. Am J Perinatol 2000; 17: 113-120.
18. McClure MM, Peiffer AM, Rosen GD, Fitch RH: Auditory processing deficits in rats with neonatal hypoxic-ischemic injury. Int J Dev Neurosci 2005; 23: 351-362.
19. McClure MM, Threlkeld SW, Rosen GD, Fitch R: Auditory processing deficits in unilaterally and bilaterally injured hypoxic-ischemic rats. Neuroreport 2005; 16: 1309-1312.
20. McClure MM, Threlkeld SW, Rosen GD, Fitch R: Rapid auditory processing and learning deficits in rats with P1 versus P7 neonatal hypoxic-ischemic injury. Behav Brain Res 2006; 172: 114-121.
21. Hill CA, Threlkeld SW, Fitch RH: Early testosterone modulated sex differences in behavioral outcome following neonatal hypoxia ischemia in rats. Int J Dev Neurosci 2011; 29: 381-388.
22. Buemi M, Cavallaro E, Floccari F, Sturiale A, Aloisi C, Trimarchi M, Crasso G, Corica F, Frisina N: Erythropoietin and the brain: from neurodevelopment to neuroprotection. Clin Trials 2002; 103: 275-282.
23. Ghezzi P, Brines M: Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004; 11: 37-44.
24. Soliz J: Erythropoietin and respiratory control at adulthood and during early postnatal life. Respir Physiol Neurobiol 2012, E-pub ahead of print.
25. Spandou E, Soubasi V, Papoutsopoulou S, Karkavelas G, Simeonidou C, Kaiki-Astara A, Guiba-Tziampiri O: Erythropoietin prevents hypoxia/ischemia- induced DNA fragmentation in an experimental model of perinatal asphyxia. Neurosci Lett 2004; 366: 24-28.
26. Bierer R, Peceny MC, Hartenberger CH, Ohls RK: Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 2006; 118:e635-e640.
27. McPhearson RJ, Juul SE: Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr Opin Pediatr 2010; 22: 138-145.
28. McAdams RM, McPhearson RJ, Mayock DE, Juul SE: Outcomes of extremely low birth weight infants given early high-dose erythropoietin. J Perinatol 2012, E-pub ahead of print.
29. Zhu C, Kang W, Xu F, Cheng X, Zhang Z, Jia L, Ji L, Guo X, Xiong H, Simbruner G, Blomgren K, Wang X: Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009; 124:e218-e226.
30. Elmahdy H, El-Mashad AR, El-Bahrawy H, El-Gohary T, El-Barbary A, Aly H: Human recombinant erythropoietin in asphyxia neonatorum: pilot trial. Pediatrics 2010; 125:e1135-e1142.
31. Aydin A, Genc K, Akhisaroglu M, Yorukoglu K, Gokmen N, Gonullu E: Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury. Brain Dev 2003; 25: 494-498.
32. Chang YS, Mu D, Wendland M, Sheldon RA, Vexler ZS, McQuillen PS, Ferriero DM: Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 2005; 58: 106-111.
33. Fan X, Heijnen CJ, van der Koolj MA, Groenendaal F, van Bel F: Beneficial effect of erythropoietin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice. Pediatr Res 2011; 69: 56-61.
34. Kumral A, Ozer E, Yilmaz O, Akhisaroglu M, Gokmen N, Duman N, Ulukus C, Genc S, Ozkan H: Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 2003; 83: 224-228.
35. Kumral A, Uysal N, Tugyan K, Sonmez A, Yilmaz O, Gokmen N, Kiray M, Genc S, Duman N, Koroglu TF, Ozkan H, Genc K: Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res 2004; 153: 77-86.
36. McClure MM, Threlkeld SW, Fitch RH: Auditory processing and learning/memory following erythropoietin administration in neonatally hypoxic-ischemic injured rats. Brain Res 2007; 1132: 203-209.
37. McClure MM, Threlkeld SW, Fitch RH: The effects of erythropoietin on auditory processing following neonatal hypoxic-ischemic injury. Brain Res 2006; 1087: 190-195.
38. Iwai M, Stetler RA, Xing J, Hu X, Gao Y, Zhang W, Chen J, Cao G: Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke 2010; 41: 1032-1037.
39. Mizuno K, Hida H, Masuda T, Nishino H, Togari H: Pretreatment with low doses of erythropoietin ameliorates brain damage in periventricular leukomalacia by targeting late oligodendrocyte progenitors: a rat model. Neonatology 2008; 94: 255-266.
40. Kim SS, Lee KH, Sung DK, Shim JW, Kim MJ, Jeon GW, Chang YS, Park WS: Erythropoietin attenuates brain injury, subventricular zone expansion, and sensorimotor deficits in hypoxic-ischemic neonatal rats. J Korean Med Sci 2008; 23: 484-491.
41. Gunn AJ, Bennet L, Gunning MI, Gluckman PD, Gunn TR: Cerebral hypothermia is not neuroprotective when started after postischemic seizures in fetal sheep. Pediatr Res 1999; 40: 274-280.
42. Karlsson M, Tooley JR, Satas S, Hobbs CE, Chakkarapani E, Stone J, Poter H, Thoresen M: Delayed hypothermia as selective head cooling or whole body cooling does not protect brain or body in newborn pig subjected to hypoxia-ischemia. Pediatr Res 2008; 64: 74-78.
43. Fitch RH, Threlkeld SW, McClure MM, Peiffer AM: Use of a modified prepulse inhibition paradigm to assess complex auditory discrimination in rodents. Brain Res Bull 2008; 70: 1-7.
44. Dame C, Juul SE, Christensen RD: The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol Neonate 2001; 79: 228-235.
45. Wen TC, Rogido M, Genetta T, Sola A: Permanent focal cerebral ischemia activates erythropoietin receptor in the neonatal rat brain. Neuroci Lett 2004; 355: 165-168.
46. Juul SE, Stallings SA, Christensen RD: Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury. Pediatr Res 1999; 46: 543-547.
47. Northington FJ, Ferriero DM, Graham EM, Traystman RJ, Martin LJ: Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiol Dis 2001; 8: 207-219.
48. Sola A, Rogido M, Lee BH, Genetta T, Wen TC: Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr Res 2005; 57: 481-487.
49. Nakajima W, Ishida A, Lange MS, Gabrielson KL, Wilson MA, Martin LJ, Blue ME, Johnston MV: Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci 2000; 20: 7994-8004.
50. Statler PA, McPhearson RJ, Bauer LA, Kellert BA, Juul SE: Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res 2007; 61: 671-675.
51. Banasiak KJ, Xia Y, Haddad GG: Mechanisms underlying hypoxia-induce neuronal apoptosis. Prog Neurobiol 2000; 62: 215-249.
52. Xu X, Dia H, Shi Y: Erythropoietin protects primary cultures of rat cortical neurons from hypoxia-induced toxicity through attenuating both glutamate release and NMDA receptor evoked neurotoxicity pathway. Pharmazie 2009; 64: 210-213.
53. Sun Y, Calvert JW, Zhang JH: Neonatal hypoxia/ ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 2005; 36: 1672-1678.
54. Sun Y, Zhou C, Polk P, Nanda A, Zhang JH: Mechanisms of erythropoietin-induced brain protection in neonatal hypoxia-ischemia rat model. J Cereb Blood Flow Metab 2004; 24: 259-270.
55. Yamada M, Burke C, Colditz P, Johnson DW, Gobe G: Erythropoietin protects against apoptosis and increases expression of nonneuronal cell markers in the hypoxia-injured developing brain. J Pathol 2011; 224: 101-109.
56. Brissaud O, Villega F, Pieter Konsman J, Sanchez S, Franconi JM, Chateil JF, Bouzier-Sore AK: Short-term effect of erythropoietin on brain lesions and aquaporin-4 expression in a hypoxic-ischemic neonatal rat model assessed by magnetic resonance diffusion weighted imaging and immunohistochemistry. Pediatr Res 2010; 68: 123-127.
57. Kumral A, Genc S, Ozer E, Yilmaz O, Gokmen N, Koroglu T, Duman N, Genc K: Erythropoietin downregulates Bax and DP5 proapoptoic gene expression in neonatal hypoxic- ischemic brain injury. Bio Neonate 2006; 89: 205-210.
58. Gonzalez FF, Abel R, Almli CR, Mu D, Wendland M, Ferriero DM: Erythropoietin sustains cognitive function and brain volume after neonatal stoke. Dev Neurosci 2008; 31: 403-411.
59. Iwai M, Stetler RA, Xing J, Hu X, Gao Y, Zhang W, Chen J, Cao G: Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic ischemic brain injury. Stroke 2010; 41: 1032-1037.
60. Keller M, Yang J, Griesmaier E, Gorna A, Sarkozy G, Urbanek M, Gressens P, Simbruner G: Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice. Neurobiol Dis 2006; 24: 357-366.